SCHEMBL926005

SCHEMBL926005

NC(=O)C(OCC(F)(F)F)Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.41
POLB P06746 1/20 0.41
PPARG P37231 4/20 0.40
PPARA Q07869 4/20 0.40
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
S1PR2 O95136 1/20 0.38
S1PR4 O95977 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
XBP1 P17861 1/20 0.38
KMT2A Q03164 1/20 0.38
PAX8 Q06710 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
S1PR3 Q99500 1/20 0.38
S1PR5 Q9H228 1/20 0.38
EPHX1 P07099 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9116662 0.80 MTNR1A (0.42) MAPK1POLBPPARGPPARALMNA
SCHEMBL11884465 0.79 PARP10 (0.45) POLBPPARGPPARALMNAMEN1
SCHEMBL5251553 0.79 EPHX1 (0.39) POLBPPARGPPARAMEN1GAA
SCHEMBL10436877 0.78 TAAR1 (0.44) POLBPPARGPPARAGAAMTNR1A
SCHEMBL11825339 0.74 EPHX1 (0.41) MAPK1POLBLMNAMEN1KMT2A
SCHEMBL926008 0.74 PARP10 (0.36) POLBPPARGPPARAMEN1GAA
SCHEMBL10807566 0.73 CES1 (0.42) MAPK1POLBLMNAHTTMEN1
SCHEMBL7669989 0.73 POLB (0.42) POLBPPARGPPARALMNAMEN1
SCHEMBL29138026 0.72 SLC6A4 (0.41) MAPK1PPARGPPARAMEN1KMT2A
SCHEMBL28157165 0.71 PARP10 (0.39) POLBPPARGPPARAMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021473-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE-IV RANBAXY LABORATORIES LIMITED 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021473-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE-IV PDE4A, PDE4B, PDE4C MAPK1 1562/4885POLB 1077/4885PPARG 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.